|
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 in Preventing SARS-CoV-2 Infection
Posted 3/29/2021 11:35:12 AM by PitterPatter11 Since a lot of people on the other thread were posting that the vaccine may not prevent people from being asymptomatic spreaders, here is the most up to date information from the CDC: Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 in Preventing SARS-CoV-2 Infection "Prospective cohorts of 3,950 health care personnel, first responders, and other essential and frontline workers completed weekly SARS-CoV-2 testing for 13 consecutive weeks. Under real-world conditions, mRNA vaccine effectiveness of full immunization (=14 days after second dose) was 90% against SARS-CoV-2 infections regardless of symptom status; vaccine effectiveness of partial immunization (=14 days after first dose but before second dose) was 80%." |